IONS
IONIS PHARMACEUTICALS INC
IONIS PHARMACEUTICALS INC (IONS) has 24 SEC Form 4 filings (121 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Jul 9, 2026.
The most active filer is Chief Executive Officer Monia Brett P with 6 filings. Insiders have net sold $58.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Brett Monia
- Employees:1,069
- HQ:Carlsbad, CA, US
- IPO:1991-05-17
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$94.7M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Market Cap
$9.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
BENNETT C FRANKFirst in 4 months | EVP, Chief Scientific Officer | Sale | 20,536 | $1.7M | Jul 9 | SEC ↗ |
Diaz Allene M.First in 4 months | Director | Sale | 10,111 | $864K | Jul 9 | SEC ↗ |
Kordasiewicz Holly B.First filing | EVP, Chief Development Officer | Sale | 362 | $31K | Jul 9 | SEC ↗ |
KLEIN JOSEPH IIIFirst filing | Director | Sale | 11,518 | $910K | Jul 6 | SEC ↗ |
Baroldi JosephFirst in 4 months | EVP, Chief Business Officer | Sale | 5,635 | $452K | Jun 30 | SEC ↗ |
O'NEIL PATRICK R.First in 9 months | EVP CLO & General Counsel | Sale | 3,069 | $246K | Jun 30 | SEC ↗ |
Schneider EugeneFirst filing | EVP, Chf Clinical Develop Ofcr | Sale | 26,000 | $2.1M | Jun 30 | SEC ↗ |
Monia Brett PFirst in 4 months | Chief Executive Officer | Sale | 14,565 | $1.1M | Jun 26 | SEC ↗ |
Monia Brett PFirst in 4 months | Chief Executive Officer | Sale | 21,072 | $1.7M | Jun 26 | SEC ↗ |
Monia Brett PFirst in 4 months | Chief Executive Officer | Sale | 50,000 | $4.0M | Jun 26 | SEC ↗ |
Swayze EricFirst filing | EVP Research | Sale | 10,602 | $839K | Jun 26 | SEC ↗ |
HOUGEN ELIZABETH LFirst filing | EVP, Finance & CFO | Sale | 215,048 | $15.6M | Mar 18 | SEC ↗ |
HOUGEN ELIZABETH LFirst filing | EVP, Finance & CFO | Sale | 10,172 | $745K | Mar 18 | SEC ↗ |
Monia Brett PFirst in 6 months | Chief Executive Officer | Sale | 126,670 | $9.5M | Mar 11 | SEC ↗ |
Monia Brett PFirst in 6 months | Chief Executive Officer | Sale | 34,103 | $2.6M | Mar 11 | SEC ↗ |
Jenne KyleFirst filing | EVP, Chf GL Pdt Str Ofcr | Sale | 37,277 | $2.8M | Mar 11 | SEC ↗ |
| EVP, Chief Human Resources Ofc | Sale | 20,106 | $1.6M | Mar 5 | SEC ↗ | |
BENNETT C FRANKFirst in 6 months | EVP, Chief Scientific Officer | Sale | 85,089 | $6.7M | Mar 5 | SEC ↗ |
Baroldi JosephFirst filing | EVP, Chief Business Officer | Sale | 6,220 | $496K | Mar 5 | SEC ↗ |
Baroldi JosephFirst filing | EVP, Chief Business Officer | Sale | 439 | $35K | Mar 5 | SEC ↗ |
Diaz Allene M.First filing | Director | Sale | 54,878 | $4.4M | Mar 5 | SEC ↗ |
Devers Shannon L.First filing | EVP, Chief Human Resources Ofc | Sale | 44,199 | $3.8M | Jan 9 | SEC ↗ |
| EVP, Chief Development Officer | Sale | 1,601 | $120K | Nov 7 | SEC ↗ | |
| EVP, Chief Development Officer | Sale | 33,038 | $2.5M | Nov 7 | SEC ↗ | |
WENDER JOSEPH HFirst filing | Director | Sale | 16,800 | $1.2M | Nov 3 | SEC ↗ |
WENDER JOSEPH HFirst filing | Director | Sale | 11,200 | $842K | Nov 3 | SEC ↗ |
Geary Richard SFirst filing | EVP, Chief Development Officer | Sale | 89,249 | $6.7M | Nov 3 | SEC ↗ |
Geary Richard SFirst filing | EVP, Chief Development Officer | Sale | 1,680 | $126K | Nov 3 | SEC ↗ |
| EVP CLO & General Counsel | Sale | 13,441 | $937K | Oct 8 | SEC ↗ | |
O'NEIL PATRICK R.First filing | EVP CLO & General Counsel | Sale | 13,050 | $711K | Sep 4 | SEC ↗ |
O'NEIL PATRICK R.First filing | EVP CLO & General Counsel | Sale | 76,850 | $4.7M | Sep 4 | SEC ↗ |
Monia Brett PFirst filing | Chief Executive Officer | Sale | 203,814 | $12.3M | Sep 4 | SEC ↗ |
BENNETT C FRANKFirst filing | EVP, Chief Scientific Officer | Sale | 5,000 | $246K | Sep 4 | SEC ↗ |
BENNETT C FRANKFirst filing | EVP, Chief Scientific Officer | Sale | 33,909 | $2.1M | Sep 4 | SEC ↗ |
Related companies
IONIS PHARMACEUTICALS INC is in the Healthcare sector.